Cetuximab is a monoclonal antibody used to treat various cancers, including colorectal and head and neck cancers. It works by inhibiting epidermal growth factor receptor (EGFR) signaling, reducing tumor growth. Cetuximab is effective in managing specific cancer types. In summary, it plays a vital role in targeted cancer therapy.
Cetuximab binds to EGFR, preventing ligand binding and inhibiting downstream signaling pathways that promote tumor growth.